Literature DB >> 19406964

Association of genetic variants with chronic kidney disease in Japanese individuals.

Tetsuro Yoshida1, Kimihiko Kato, Tetsuo Fujimaki, Kiyoshi Yokoi, Mitsutoshi Oguri, Sachiro Watanabe, Norifumi Metoki, Hidemi Yoshida, Kei Satoh, Yukitoshi Aoyagi, Yutaka Nishigaki, Masashi Tanaka, Yoshinori Nozawa, Genjiro Kimura, Yoshiji Yamada.   

Abstract

BACKGROUND AND OBJECTIVES: Although genetic linkage analyses and association studies have implicated several loci and candidate genes in predisposition to chronic kidney disease (CKD), the genes that underlie genetic susceptibility to this condition have remained uncharacterized. The purpose of the present study was to identify genetic variants that confer susceptibility to CKD in Japanese individuals. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: The study population comprised 5217 Japanese individuals (2955 men, 2262 women), including 778 subjects (480 men, 298 women) with CKD [estimated GFR (eGFR), <50 ml min(-1) 1.73 m(-2)] and 4439 controls (2475 men, 1964 women; eGFR, > or =60 ml min(-1) 1.73 m(-2)). The genotypes for 40 polymorphisms of 32 candidate genes were determined.
RESULTS: The chi-square test and multivariable logistic regression analysis with adjustment for covariates revealed that the -219G-->T polymorphism of APOE, the -519A-->G of MMP1, the -866G-->A of UCP2, the -1607/1G-->2G of MMP1, the A-->G (Lys45Glu) of MMP3, the G-->A (Ala163Thr) of AGTR1, the G-->A (Gly670Arg) of PECAM1, and the -55C-->T of UCP3 were significantly (false discovery rate <0.05) associated with CKD. Comparison of allele frequencies of these polymorphisms by the chi-square test between subgroups of CKD and control subjects individually matched for covariates revealed that the -519A-->G of MMP1 and the -866G-->A of UCP2 were significantly (P < 0.05) associated with CKD.
CONCLUSIONS: MMP1 and UCP2 may be susceptibility loci for CKD in Japanese individuals. Determination of genotypes for these polymorphisms may prove informative for prediction of genetic risk for CKD.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19406964      PMCID: PMC2676181          DOI: 10.2215/CJN.04350808

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  19 in total

1.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.

Authors: 
Journal:  Am J Kidney Dis       Date:  2002-02       Impact factor: 8.860

2.  Smoking and the kidney.

Authors:  Stephan R Orth
Journal:  J Am Soc Nephrol       Date:  2002-06       Impact factor: 10.121

3.  Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies.

Authors:  Daniel E Weiner; Hocine Tighiouart; Manish G Amin; Paul C Stark; Bonnie MacLeod; John L Griffith; Deeb N Salem; Andrew S Levey; Mark J Sarnak
Journal:  J Am Soc Nephrol       Date:  2004-05       Impact factor: 10.121

4.  High-throughput DNA typing of HLA-A, -B, -C, and -DRB1 loci by a PCR-SSOP-Luminex method in the Japanese population.

Authors:  Yoshiki Itoh; Nobuhisa Mizuki; Tsuyako Shimada; Fumihiro Azuma; Mitsuo Itakura; Koichi Kashiwase; Eri Kikkawa; Jerzy K Kulski; Masahiro Satake; Hidetoshi Inoko
Journal:  Immunogenetics       Date:  2005-11-08       Impact factor: 2.846

5.  Interleukin-1 gene cluster polymorphisms predict risk of ESRD.

Authors:  James B Wetmore; Adriana M Hung; David H Lovett; Saunak Sen; Omer Quershy; Kirsten L Johansen
Journal:  Kidney Int       Date:  2005-07       Impact factor: 10.612

6.  IgA nephropathy, the most common cause of glomerulonephritis, is linked to 6q22-23.

Authors:  A G Gharavi; Y Yan; F Scolari; F P Schena; G M Frasca; G M Ghiggeri; K Cooper; A Amoroso; B F Viola; G Battini; G Caridi; C Canova; A Farhi; V Subramanian; C Nelson-Williams; S Woodford; B A Julian; R J Wyatt; R P Lifton
Journal:  Nat Genet       Date:  2000-11       Impact factor: 38.330

7.  Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization.

Authors:  Alan S Go; Glenn M Chertow; Dongjie Fan; Charles E McCulloch; Chi-yuan Hsu
Journal:  N Engl J Med       Date:  2004-09-23       Impact factor: 91.245

8.  Effect of TCN2 776C>G on vitamin B12 cellular availability in end-stage renal disease patients.

Authors:  Manuela Födinger; Mario Veitl; Sonja Skoupy; Jadwiga Wojcik; Claudia Röhrer; Wolfgang Hagen; Heidi Puttinger; Anna-Christine Hauser; Andreas Vychytil; Gere Sunder-Plassmann
Journal:  Kidney Int       Date:  2003-09       Impact factor: 10.612

9.  Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: a patient-level meta-analysis.

Authors:  Tazeen H Jafar; Paul C Stark; Christopher H Schmid; Marcia Landa; Giuseppe Maschio; Paul E de Jong; Dick de Zeeuw; Shahnaz Shahinfar; Robert Toto; Andrew S Levey
Journal:  Ann Intern Med       Date:  2003-08-19       Impact factor: 25.391

10.  Chronic Kidney Disease Japan Cohort (CKD-JAC) study: design and methods.

Authors:  Enyu Imai; Seiichi Matsuo; Hirofumi Makino; Tsuyoshi Watanabe; Tadao Akizawa; Kosaku Nitta; Satoshi Iimuro; Yasuo Ohashi; Akira Hishida
Journal:  Hypertens Res       Date:  2008-06       Impact factor: 3.872

View more
  18 in total

Review 1.  Susceptibility genes in common complex kidney disease.

Authors:  Jasmin Divers; Barry I Freedman
Journal:  Curr Opin Nephrol Hypertens       Date:  2010-01       Impact factor: 2.894

2.  APOE and CYP2E1 polymorphisms, alcohol consumption, and Parkinson's disease in a Japanese population.

Authors:  Chikako Kiyohara; Yoshihiro Miyake; Midori Koyanagi; Takahiro Fujimoto; Senji Shirasawa; Keiko Tanaka; Wakaba Fukushima; Satoshi Sasaki; Yoshio Tsuboi; Tatsuo Yamada; Tomoko Oeda; Takami Miki; Nobutoshi Kawamura; Nobutaka Sakae; Hidenao Fukuyama; Yoshio Hirota; Masaki Nagai
Journal:  J Neural Transm (Vienna)       Date:  2011-03-01       Impact factor: 3.575

3.  MMP-2 (-1306 C/T) Polymorphism Affects Serum Matrix Metalloproteinase (MMP)-2 Levels and Correlates with Chronic Obstructive Pulmonary Disease Severity: A Case-Control Study of MMP-1 and -2 in a Tunisian Population.

Authors:  Sarra Bchir; Hela Ben Nasr; Amel Ben Anes; Mohamed Benzarti; Abdelhamid Garrouch; Zouhair Tabka; Karim Chahed
Journal:  Mol Diagn Ther       Date:  2016-12       Impact factor: 4.074

4.  Angiotensin II type 1 receptor variants alter endosomal receptor-β-arrestin complex stability and MAPK activation.

Authors:  Yubo Cao; Sahil Kumar; Yoon Namkung; Laurence Gagnon; Aaron Cho; Stéphane A Laporte
Journal:  J Biol Chem       Date:  2020-07-23       Impact factor: 5.157

5.  Contribution of mitochondrial function to exercise-induced attenuation of renal dysfunction in spontaneously hypertensive rats.

Authors:  Qi Gu; Li Zhao; Yan-Ping Ma; Jian-Dong Liu
Journal:  Mol Cell Biochem       Date:  2015-05-12       Impact factor: 3.396

6.  Angiotensin type 1 receptor resistance to blockade in the opossum proximal tubule cell due to variations in the binding pocket.

Authors:  Ravi Nistala; Bradley T Andresen; Lakshmi Pulakat; Alex Meuth; Catherine Sinak; Chirag Mandavia; Thomas Thekkumkara; Robert C Speth; Adam Whaley-Connell; James R Sowers
Journal:  Am J Physiol Renal Physiol       Date:  2013-02-06

7.  A Common APOE Polymorphism Is an Independent Risk Factor for Reduced Glomerular Filtration Rate in the Spanish RENASTUR Cohort.

Authors:  Eliecer Coto; Juan Gómez; Beatriz Tavira; Salvador Tranche; Francisco Ortega; María I Rodríguez; Emilio Sánchez; Rafael Marín; Ana I Corao; Jorge Arenas; Victoria Alvarez
Journal:  Cardiorenal Med       Date:  2013-05-16       Impact factor: 2.041

8.  Association of genetic variants with chronic kidney disease in Japanese individuals with or without hypertension or diabetes mellitus.

Authors:  Tetsuro Yoshida; Kimihiko Kato; Kiyoshi Yokoi; Mitsutoshi Oguri; Sachiro Watanabe; Norifumi Metoki; Hidemi Yoshida; Kei Satoh; Yukitoshi Aoyagi; Yoshinori Nozawa; Yoshiji Yamada
Journal:  Exp Ther Med       Date:  2010-01-01       Impact factor: 2.447

9.  Pro-/anti-inflammatory cytokine gene polymorphisms and chronic kidney disease: a cross-sectional study.

Authors:  Rieko Okada; Kenji Wakai; Mariko Naito; Emi Morita; Sayo Kawai; Nobuyuki Hamajima; Megumi Hara; Naoyuki Takashima; Sadao Suzuki; Toshiro Takezaki; Keizo Ohnaka; Kokichi Arisawa; Hiroshi Hirohata; Keitaro Matsuo; Haruo Mikami; Michiaki Kubo; Hideo Tanaka
Journal:  BMC Nephrol       Date:  2012-01-09       Impact factor: 2.388

10.  Combined effect of mitochondrial DNA 5178 C/A polymorphism and alcohol consumption on estimated glomerular filtration rate in male Japanese health check-up examinees: a cross-sectional study.

Authors:  Akatsuki Kokaze; Mamoru Ishikawa; Naomi Matsunaga; Kanae Karita; Masao Yoshida; Naoki Shimada; Tadahiro Ohtsu; Takako Shirasawa; Hirotaka Ochiai; Hiromi Hoshino; Yutaka Takashima
Journal:  BMC Nephrol       Date:  2013-02-12       Impact factor: 2.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.